Clinical Trials
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0517
A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma -
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
08-01-2007
Closed
Phase
Accrual
19%
SWOG Clinical Trial Number
S0423
Phase II Trial of Pemetrexed for Advanced Chondrosarcomas
Research Committee(s)
Sarcoma
Activated
09-01-2005
Closed
01-15-2007
Closed
Phase
SWOG Clinical Trial Number
S0334
Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma
Research Committee(s)
Myeloma
Activated
09-01-2005
Closed
06-15-2007
Closed
Phase
Accrual
53%
SWOG Clinical Trial Number
S0437
Prostate Cancer Prevention Trial (PCPT) Companion Long Term Follow Up Study for Men Diagnosed with Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
09-01-2005
Closed
03-01-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0430
Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
08-15-2005
Closed
09-01-2007
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
S0417
A Phase II Study of Bortezomib (Velcade™, PS-341), Thalidomide, and Dexamethasone in Patients With Refractory Multiple Myeloma
Research Committee(s)
Myeloma
Activated
08-01-2005
Closed
06-15-2007
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0346
Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma
Research Committee(s)
Sarcoma
Activated
07-15-2005
Closed
12-01-2006
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0501
Nonmyeloablative Allogeneic Stem Cell Transplantation for Relapsed Hodgkin's or Non-Hodgkin's Lymphoma After Autologous Transplantation (A BMT Study)
Research Committee(s)
Lymphoma
Activated
07-01-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0435
A Phase II Trial of BAY 43-9006 (NSC-724772) in Patients with Platinum-Treated Extensive Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-2005
Closed
02-15-2007
Closed
Phase
Accrual
13%
SWOG Clinical Trial Number
S0217
Adjuvant Chemo-Radiotherapy with Combination of Cisplatin (NSC-119875)and Docetaxel (NSC-628503) After Complete Resection of Locally Advanced (Stage III and IV) Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
07-01-2005
Closed
01-10-2007
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
S0431
Phase II Study of Trastuzumab (NSC-688097) in Advanced High Grade Salivary Gland Carcinoma
Activated
07-01-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0515
Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL
Research Committee(s)
Lymphoma
Activated
06-15-2005
Closed
09-15-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0508
Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Melanoma
Research Committee(s)
Melanoma
Activated
06-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S0414
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2005
Closed
09-01-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0333
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0340
A Prospective Observational Study of Patients with Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan
Research Committee(s)
Myeloma
Activated
04-15-2005
Closed
02-15-2007
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0418
A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2005
Closed
05-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0329
Phase II Study of Biweekly Gemcitabine and Paclitaxel (GEMTAX) Combination in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
01-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0347
A Randomized Study of Weekly Vinorelbine (Navelbine®) Alone or in Combination With Trastuzumab (Herceptin®) (NSC-688097) for Patients With Her-2 Positive Metastatic Breast Cancer Whose Tumors Have Progressed After Taxane + Trastuzumab Combination Therapy – Phase III
Research Committee(s)
Breast Cancer
Activated
12-15-2004
Closed
02-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0413
Phase II Study of GW572016 (NSC #727989) as First Line Therapy in Patients with Advanced or Metastatic Gastric Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-2004
Closed
05-15-2006